University Of Bordeaux — Clinical Trial Site

8 Registered trials

4 Currently recruiting

Organisation

University Of Bordeaux

Location

Bordeaux Cedex, France

Identifier

ORG-100030623

Address

351 Cours De La Liberation, Cs 10004, 33405, France

Departments

Hémato Onco Ped
Hématologie
Nephrology
Neuropédiatric department, Children Hospital
pediatric oncology
Rhumatologie
Service de Pathologie
Service de Pédiatrie médicale

Clinical trials at this site (8)

Search interface

BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending

2024-516115-24-00 High risk relapsed neuroblastoma (relapsed or progresse 9
An open-label, single-arm extension study to evaluate the long-term safety, tolerability, and efficacy of KL1333 (napazimone) in patients wi… Pending

2025-524367-20-00 Adult patients with primary mitochondrial disease 4
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting

2024-514135-17-00 Immunoglobulin A Nephropathy 5 2024-11-28
Justification AnD evaluation, in pOlymyalgia RhEumatica, of BARIcitinib versus placebo (JADORE-BARI study) Recruiting

2024-518385-26-01 Polymyalgia Rheumatica (PMR) 5 2025-12-18
A clinical study in 3 parts with a microdystrophin (called GNT0004), a new gene therapy in boys with Duchenne disease who can still walk. Th… Recruiting

2023-505187-11-00 Duchenne Muscular Dystrophy 7 2021-03-01
Study describing the efficacy and safety of regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas Recruiting

2024-514637-37-00 Patients with bone sarcomas other than chordoma, who ha 5 2020-02-11
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem… Ended

2023-504176-25-00 Acute Myeloid Leukemia 9 2024-08-08
Myechild 01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Fin… Ended

2024-516112-21-00 Newly diagnosed acute myeloid leukaemia (AML), high ris 5 2017-11-20